Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemazyre + Paclitaxel in FGFR-mutated Gastric Cancer
NCT05529667Phase 2Completed
- Sponsor
- Yonsei University
- Start
- May 2019
- Primary completion
- Aug 2023
- Modality
- Fragment-Derived Small Molecules, Reversible Covalent Inhibitors, Bivalent/Multivalent Binders
- Countries
- 1
01
Overview
A Phase 2 trial of pemigatinib in gastric cancer (GC), sponsored by Yonsei University. Started May 2019; status: completed.
02
Drugs
pemigatinib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT05529667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05529667.